These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 6142906)
1. Pharmacokinetic noninteraction of triazolam and ethanol. Ochs HR; Greenblatt DJ; Arendt RM; Hübbel W; Shader RI J Clin Psychopharmacol; 1984 Apr; 4(2):106-7. PubMed ID: 6142906 [TBL] [Abstract][Full Text] [Related]
2. Interaction of cimetidine with the triazolobenzodiazepines alprazolam and triazolam. Abernethy DR; Greenblatt DJ; Divoll M; Moschitto LJ; Harmatz JS; Shader RI Psychopharmacology (Berl); 1983; 80(3):275-8. PubMed ID: 6137021 [TBL] [Abstract][Full Text] [Related]
3. Triazolam and ethanol interaction: kinetic and dynamic consequences. Dorian P; Sellers EM; Kaplan HL; Hamilton C; Greenblatt DJ; Abernethy D Clin Pharmacol Ther; 1985 May; 37(5):558-62. PubMed ID: 2859136 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of triazolam in geriatric patients. Dehlin O; Björnson G; Börjesson L; Abrahamsson L; Smith RB Eur J Clin Pharmacol; 1983; 25(1):91-4. PubMed ID: 6137388 [TBL] [Abstract][Full Text] [Related]
5. Mibefradil but not isradipine substantially elevates the plasma concentrations of the CYP3A4 substrate triazolam. Backman JT; Wang JS; Wen X; Kivistö KT; Neuvonen PJ Clin Pharmacol Ther; 1999 Oct; 66(4):401-7. PubMed ID: 10546924 [TBL] [Abstract][Full Text] [Related]
6. Differential impairment of triazolam and zolpidem clearance by ritonavir. Greenblatt DJ; von Moltke LL; Harmatz JS; Durol AL; Daily JP; Graf JA; Mertzanis P; Hoffman JL; Shader RI J Acquir Immune Defic Syndr; 2000 Jun; 24(2):129-36. PubMed ID: 10935688 [TBL] [Abstract][Full Text] [Related]
7. Differential effect of isoniazid on triazolam oxidation and oxazepam conjugation. Ochs HR; Greenblatt DJ; Knüchel M Br J Clin Pharmacol; 1983 Dec; 16(6):743-6. PubMed ID: 6140941 [TBL] [Abstract][Full Text] [Related]
8. Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity. Greenblatt DJ; Divoll M; Abernethy DR; Moschitto LJ; Smith RB; Shader RI Br J Clin Pharmacol; 1983 Mar; 15(3):303-9. PubMed ID: 6133545 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects. Pourbaix S; Desager JP; Hulhoven R; Smith RB; Harvengt C Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):447-51. PubMed ID: 2864320 [TBL] [Abstract][Full Text] [Related]
10. Relationship between single oral dose pharmacokinetics of alprazolam and triazolam. Otani K; Yasui N; Furukori H; Kaneko S; Tasaki H; Ohkubo T; Nagasaki T; Sugawara K; Hayashi K Int Clin Psychopharmacol; 1997 May; 12(3):153-7. PubMed ID: 9248872 [TBL] [Abstract][Full Text] [Related]
11. Assay of triazolam in plasma by capillary gas chromatography. Jochemsen R; Breimer DD J Chromatogr; 1981 May; 223(2):438-44. PubMed ID: 6114106 [No Abstract] [Full Text] [Related]
12. Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics. Stoehr GP; Kroboth PD; Juhl RP; Wender DB; Phillips JP; Smith RB Clin Pharmacol Ther; 1984 Nov; 36(5):683-90. PubMed ID: 6149030 [TBL] [Abstract][Full Text] [Related]